Literature DB >> 31777017

Neuropharmacological Effect and Clinical Applications of Ganoderma (Lingzhi).

Xiangyu Cui1, Yonghe Zhang2.   

Abstract

Ganoderma lucidum (G. lucidum, Lingzhi) is a kind of medical mushroom with various pharmacological compounds. It has been used for clinical applications for thousands of years as a highly nutritious and significantly effective medicinal herb. Compared with its immunomodulatory effect, there are a few studies on the neuropharmacological actions of Ganoderma, and the mechanism has not been fully elucidated. As far as we know, Ganoderma regulate the central nervous system (CNS) at least in part through its immunomodulatory activity. The neuropharmacological effects of G. lucidum mainly include but not limited to sedative and hypnotic, neuroprotective, antinociceptive and analgesic, antiepileptic, and antidepressant effects. Clinical trials of G. lucidum in the patients with these disorders are still rare. To date, there are no Ganoderma-related drugs approved by the US Food and Drug Administration (FDA). In this chapter, we will summarize and elucidate recent progress of such effects of Ganoderma and its ingredients from both the preclinical and clinical points of view.

Entities:  

Keywords:  Antidepressant effects; Antiepileptic effects; Antinociceptive and analgesic effects; Ganoderma; Neuroprotective effects; Sedative and hypnotic effects

Mesh:

Substances:

Year:  2019        PMID: 31777017     DOI: 10.1007/978-981-32-9421-9_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Antimetastatic Effects of Ganoderma lucidum Polysaccharide Peptide on B16-F10-luc-G5 Melanoma Mice With Sleep Fragmentation.

Authors:  Haocheng Xian; Jiayi Li; Yimeng Zhang; Ditian Li; Yinan Zhu; Siyan Li; Zhelun Tan; Zhibin Lin; Xuejun Li; Yan Pan
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

2.  Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis.

Authors:  Yu Qiu; Zhu-Jun Mao; Ye-Ping Ruan; Xin Zhang
Journal:  BMC Microbiol       Date:  2021-10-29       Impact factor: 3.605

3.  Self-Medication with Ganoderma lucidum ("Reishi") to Combat Parkinson's Disease Symptoms: A Single Case Study.

Authors:  Kim P C Kuypers
Journal:  J Med Food       Date:  2020-11-09       Impact factor: 2.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.